OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Post-Conference Perspectives: Advances in Chronic and Acute Graft-versus-Host Disease

home / news-network / advances-in-chronic-acute-gvhd
Treatment Landscape of Graft-Versus-Host Disease

EP. 1: Treatment Landscape of Graft-Versus-Host Disease

December 21st 2019
Approval of Ruxolitinib: Steroid-Refractory Acute GVHD

EP. 2: Approval of Ruxolitinib: Steroid-Refractory Acute GVHD

December 21st 2019
Clinical Trials of Itacitinib for Chronic and Acute GVHD

EP. 3: Clinical Trials of Itacitinib for Chronic and Acute GVHD

December 21st 2019
Posttransplant Cyclophosphamide for GVHD

EP. 4: Posttransplant Cyclophosphamide for GVHD

December 21st 2019
The Future of Treating GVHD

EP. 5: The Future of Treating GVHD

December 21st 2019
Historical Management of Graft-Versus-Host Disease

EP. 6: Historical Management of Graft-Versus-Host Disease

December 21st 2019
Ruxolitinib: Treatment of Steroid-Refractory Acute GVHD

EP. 7: Ruxolitinib: Treatment of Steroid-Refractory Acute GVHD

December 21st 2019
Itacitinib Clinical Trials for Chronic and Acute GVHD

EP. 8: Itacitinib Clinical Trials for Chronic and Acute GVHD

December 21st 2019
Novel-Based Approaches in Treating GVHD

EP. 9: Novel-Based Approaches in Treating GVHD

December 21st 2019
Post-Transplant Cyclophosphamide and Unmet Needs in GVHD

EP. 10: Post-Transplant Cyclophosphamide and Unmet Needs in GVHD

December 21st 2019

Latest Conference Coverage

Final PICCOLO Data Underscore Mirvetuximab Soravtansine’s Efficacy in Later-Line Frα+ Platinum-Sensitive Ovarian Cancer

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact